Terumo Corporation

TSE:4543 Stock Report

Market Cap: JP¥4.5t

Terumo Valuation

Is 4543 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 4543 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 4543 (¥3044) is trading below our estimate of fair value (¥3067)

Significantly Below Fair Value: 4543 is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4543?

Key metric: As 4543 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 4543. This is calculated by dividing 4543's market cap by their current earnings.
What is 4543's PE Ratio?
PE Ratio37.7x
EarningsJP¥119.49b
Market CapJP¥4.51t

Price to Earnings Ratio vs Peers

How does 4543's PE Ratio compare to its peers?

The above table shows the PE ratio for 4543 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average28.8x
7733 Olympus
32.2x14.4%JP¥2.8t
6869 Sysmex
35.8x13.0%JP¥1.9t
6849 Nihon Kohden
38.4x20.1%JP¥364.3b
7716 Nakanishi
8.8x-5.8%JP¥190.9b
4543 Terumo
37.7x12.1%JP¥4.5t

Price-To-Earnings vs Peers: 4543 is expensive based on its Price-To-Earnings Ratio (37.7x) compared to the peer average (28.8x).

Price to Earnings Ratio vs Industry

How does 4543's PE Ratio compare vs other companies in the JP Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
4543 37.7xIndustry Avg. 14.2xNo. of Companies7PE01224364860+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 4543 is expensive based on its Price-To-Earnings Ratio (37.7x) compared to the JP Medical Equipment industry average (14.4x).

Price to Earnings Ratio vs Fair Ratio

What is 4543's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4543 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio37.7x
Fair PE Ratio31.6x

Price-To-Earnings vs Fair Ratio: 4543 is expensive based on its Price-To-Earnings Ratio (37.7x) compared to the estimated Fair Price-To-Earnings Ratio (31.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 4543 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentJP¥3,044.00
JP¥3,328.57
+9.3%
10.1%JP¥3,810.00JP¥2,500.00n/a14
Nov ’25JP¥2,886.50
JP¥3,254.29
+12.7%
9.8%JP¥3,700.00JP¥2,500.00n/a14
Oct ’25JP¥2,727.00
JP¥3,250.71
+19.2%
10.0%JP¥3,700.00JP¥2,500.00n/a14
Sep ’25JP¥2,689.50
JP¥3,215.38
+19.6%
10.4%JP¥3,700.00JP¥2,500.00n/a13
Aug ’25JP¥2,686.00
JP¥3,143.08
+17.0%
10.3%JP¥3,600.00JP¥2,500.00n/a13
Jul ’25JP¥2,548.00
JP¥3,093.08
+21.4%
10.3%JP¥3,600.00JP¥2,500.00n/a13
Jun ’25JP¥2,670.00
JP¥3,081.54
+15.4%
10.5%JP¥3,600.00JP¥2,500.00n/a13
May ’25JP¥2,659.00
JP¥2,950.83
+11.0%
12.6%JP¥3,550.00JP¥2,450.00n/a12
Apr ’25JP¥2,736.50
JP¥2,919.58
+6.7%
13.2%JP¥3,550.00JP¥2,450.00n/a12
Mar ’25JP¥2,962.00
JP¥2,861.25
-3.4%
12.9%JP¥3,550.00JP¥2,450.00n/a12
Feb ’25JP¥2,507.50
JP¥2,585.00
+3.1%
9.1%JP¥3,100.00JP¥2,150.00n/a12
Jan ’25JP¥2,311.00
JP¥2,543.33
+10.1%
11.4%JP¥3,200.00JP¥2,125.00n/a12
Dec ’24JP¥2,350.00
JP¥2,532.31
+7.8%
10.5%JP¥3,200.00JP¥2,125.00n/a13
Nov ’24JP¥2,089.50
JP¥2,430.77
+16.3%
13.1%JP¥3,200.00JP¥1,900.00JP¥2,886.5013
Oct ’24JP¥1,981.50
JP¥2,382.50
+20.2%
9.9%JP¥2,700.00JP¥1,900.00JP¥2,727.0010
Sep ’24JP¥2,211.50
JP¥2,411.36
+9.0%
10.2%JP¥2,750.00JP¥1,900.00JP¥2,689.5011
Aug ’24JP¥2,340.00
JP¥2,438.64
+4.2%
9.0%JP¥2,750.00JP¥1,950.00JP¥2,686.0011
Jul ’24JP¥2,281.00
JP¥2,400.00
+5.2%
10.5%JP¥2,750.00JP¥1,850.00JP¥2,548.0012
Jun ’24JP¥2,150.50
JP¥2,434.62
+13.2%
15.6%JP¥3,400.00JP¥1,850.00JP¥2,670.0013
May ’24JP¥2,053.50
JP¥2,425.00
+18.1%
16.8%JP¥3,400.00JP¥1,650.00JP¥2,659.0013
Apr ’24JP¥1,787.00
JP¥2,430.77
+36.0%
17.5%JP¥3,500.00JP¥1,650.00JP¥2,736.5013
Mar ’24JP¥1,800.00
JP¥2,466.07
+37.0%
17.0%JP¥3,500.00JP¥1,650.00JP¥2,962.0014
Feb ’24JP¥1,873.00
JP¥2,558.93
+36.6%
12.8%JP¥3,450.00JP¥2,050.00JP¥2,507.5014
Jan ’24JP¥1,873.00
JP¥2,587.50
+38.1%
13.7%JP¥3,650.00JP¥2,100.00JP¥2,311.0014
Dec ’23JP¥2,044.50
JP¥2,591.07
+26.7%
13.9%JP¥3,650.00JP¥2,150.00JP¥2,350.0014
Nov ’23JP¥2,252.50
JP¥2,594.64
+15.2%
13.8%JP¥3,650.00JP¥2,150.00JP¥2,089.5014

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Daiken Medical

JP¥14.4b

Engages in the manufacture and distribution of medical devices and equipment in Japan and internationally.

7775

JP¥502.00

7D

-0.6%

1Y

-3.5%

FINDEX

JP¥20.6b

Offers medical systems, office systems, and Healthtech products in Japan.

3649

JP¥804.00

7D

-5.3%

1Y

-10.7%

Charm Care

JP¥40.0b

Engages in nursing care business.

6062

JP¥1,226.00

7D

1.6%

1Y

2.9%